Cargando…
In vivo target protein degradation induced by PROTACs based on E3 ligase DCAF15
Autores principales: | Li, Liang, Mi, Dazhao, Pei, Haixiang, Duan, Qiuhui, Wang, Xinyue, Zhou, Wenbo, Jin, Jianping, Li, Dali, Liu, Mingyao, Chen, Yihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383041/ https://www.ncbi.nlm.nih.gov/pubmed/32713946 http://dx.doi.org/10.1038/s41392-020-00245-0 |
Ejemplares similares
-
Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
por: Zhang, Xiaoyu, et al.
Publicado: (2019) -
An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment
por: Zhang, Yuzhu, et al.
Publicado: (2022) -
Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery
por: Pei, Haixiang, et al.
Publicado: (2019) -
Aryl Sulfonamides Induce Degradation of Aryl Hydrocarbon Receptor Nuclear Translocator through CRL4(DCAF15) E3 Ligase
por: Kim, Sung Ah, et al.
Publicado: (2020) -
DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
por: Li, Fenglei, et al.
Publicado: (2022)